Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human and E. coli peptides used for predicting FAIMS CVs

ABSTRACT: Peptide ion mobility adds an extra dimension of separation to mass spectrometry-based proteomics. The ability to accurately predict peptide ion mobility would be useful to expedite assay development, or as an additional constraint for peptide identification. Although there are methods to accurately predict peptide mobility in drift tube ion mobility, more work is needed to predict mobility through the high-field asymmetric waveform ion mobility (FAIMS). Here, we show that prediction of peptide FAIMS ion mobility is not a simple regression due to peptides observed at multiple mobilities, but we successfully model this problem as multi-label classification. We trained two separate models, a random forest and a long-term short-term memory neural network. Both models had different strengths, and the ensemble average of model predictions produced higher f2 score than either model alone. Finally, we explore why the models are wrong, and demonstrate predictive performance of f2=0.66 (AUROC = 0.928) on a new test dataset of nearly 40,000 different E. coli peptides.

ORGANISM(S): Homo Sapiens Escherichia Coli

SUBMITTER: Jesse Meyer

PROVIDER: PXD021174 | panorama | Fri Jul 26 00:00:00 BST 2024

REPOSITORIES: PanoramaPublic

ACCESS DATA

Json Xml

Similar Datasets

Systemically administered HMGN1 immunostimulatory peptide with anti-PD-L1 antibody exerts synergistic antitumor effects

Project description:In this study, we explore a new combination therapy of anti-PD-L1 antibody with an immunostimulatory peptide derived from an alarmin high mobility group nucleosome binding protein 1 (HMGN1). Combination treatement of HMGN1 immunostimulatory peptide with anti-PD-L1 antibody exerted robust anti-tumor effects in Colon26 subtaneous murine model. To understand transcriptomic differences of immune cell population in the tumor-bearing mice after treated with single-agent or combination therapy of HMGN1 with anti-PD-L1 antibody, we performed transcriptome analysis on tumor tissue using 5’end Serial Analysis of Gene Expression (SAGE)-sequencing with an Ion 540 Chef kit, an Ion 540 Chip kit, and an Ion S5 Sequencer (Thermo Fisher Scientific).

2021-11-02 | GSE139291 | GEO

High-field asymmetric waveform ion mobility spectrometry interface enhances parallel reaction monitoring on an Orbitrap mass spectrometer

Project description:High-field asymmetric waveform ion mobility spectrometry (FAIMS) enables gas phase separations on a chromatographic timescale and has become a useful tool for proteomic applications. Despite its emerg-ing utility, however, the molecular determinants underlying peptide separation by FAIMS have not been systematically investigated. Here, we characterize peptide transmission in a FAIMS device across a broad range of compensation voltages (CV) and used machine learning to identify charge state and 3D electrostatic peptide potential as major contributors to peptide intensity at a given CV. We also demon-strate that the machine learning model can be used to predict optimized CV values for peptides which significantly improves parallel reaction monitoring workflows. Together these data provide insight into peptide separation by FAIMS and highlight its utility in targeted proteomic applications.

2022-03-07 | MSV000089014 | MassIVE

State-transition Modeling of Blood Transcriptome Predicts Disease Evolution and Treatment Response in Chronic Myeloid Leukemia (CML)

Project description:Chronic myeloid leukemia (CML) is initiated and initially maintained solely by the fusion gene BCR-ABL, encoding a mutant protein targeted in the clinic with tyrosine kinase inhibitors (TKIs) While TKI treatment is effective in inducing long-term remission, frequently is not curative. For these reasons, CML is an ideal disease to test our hypothesis that that transcriptome-based state-transition models accurately predict cancer evolution and treatment response. We hypothesized that transcriptome-based state-transition models accurately predict cancer evolution and treatment response.

2023-11-02 | GSE244990 | GEO

Effect of Phosphorylation on the Collision Cross Sections of Peptide Ions in Ion Mobility Spectrometry

Project description:The insertion of ion mobility spectrometry (IMS) between LC and MS can improve peptide identification in both proteomics and phosphoproteomics by providing structural information that is complementary to LC and MS, because IMS separates ions on the basis of differences in their shapes and charge states. However, it is necessary to know how phosphate groups affect the peptide collision cross sections (CCS) in order to accurately predict phosphopeptide CCS values and to maximize the usefulness of IMS. In this work, we systematically characterized the CCS values of 4,433 pairs of mono-phosphopeptide and corresponding unphosphorylated peptide ions using trapped ion mobility spectrometry (TIMS). Nearly one-third of the mono-phosphopeptide ions evaluated here showed smaller CCS values than their unphosphorylated counterparts, even though phosphorylation results in a mass increase of 80 Da. Significant changes of CCS upon phosphorylation occurred mainly in structurally extended peptides with large numbers of basic groups, possibly reflecting intramolecular interactions between phosphate and basic groups.

2021-01-14 | PXD019746 | JPOST Repository

Deep proteome analysis by DIA-MS with FAIMS

Project description:We aimed to expand the proteome coverage by single-shot measurements using optimizing high-field asymmetric waveform ion mobility spectrometry (FAIMS) parameters in DIA-MS. In addition, we analyzed host proteins in the feces of control and repeated social defeat stress (R-SDS) model mice with optimal FAIMS parameters in DIA-MS.

2022-04-28 | PXD029853 | JPOST Repository

Targeted mass spectrometry analyses of somatic mutations in colorectal cancer specimens using differential ion mobility

Project description:Identification of K-Ras and B-Raf mutations in colorectal cancer (CRC) is essential to predict patients' response to anti-EGFR therapy and formulate appropriate therapeutic strategies to improve prognosis and survival. Here, we combined parallel reaction monitoring (PRM) with high-field asymmetric waveform ion mobility (FAIMS) to enhance mass spectrometry sensitivity and improve the identification of low-abundance K-Ras and B-Raf mutations in biological samples without immunoaffinity enrichment. In targeted LC-MS/MS analyses, FAIMS reduced the occurrence of interfering ions and enhanced precursor ion purity, resulting in a three-fold improvement in the detection limit for K-Ras and B-Raf mutated peptides. In addition, ion mobility separation of isomeric peptides using FAIMS facilitated the unambiguous identification of K-Ras G12D and G13D peptides. The application of targeted LC-MS/MS analyses using FAIMS is demonstrated for the detection and quantitation of B-Raf V600E, K-Ras G12D, G13D, and G12V in CRC cell lines and primary specimens.

2023-11-20 | PXD047029 | Pride

Targeted mass spectrometry analyses of somatic mutations in colorectal cancer specimens using differential ion mobility

2023-08-14 | PXD043799 | Pride

High quality MS/MS spectrum prediction for data-dependent and -independent acquisition data analysis

Project description:Peptide fragmentation spectra are routinely predicted in the interpretation of mass spectrometry-based proteomics data. Unfortunately, the generation of fragment ions is not well enough understood to estimate fragment ion intensities accurately. Here, we demonstrate that machine learning can predict peptide fragmentation patterns in mass spectrometers with accuracy within the uncertainty of the measurements. Moreover, analysis of our models reveals that peptide fragmentation depends on long-range interactions within a peptide sequence. We illustrate the utility of our models by applying them to the analysis of both data-dependent and data-independent acquisition datasets. In the former case, we observe a significant increase in the total number of peptide identifications at fixed false discovery rate. In the latter case we demonstrate that the use of predicted MS/MS spectra is equivalent to the use of spectra from experimentallibraries, indicating that fragmentation libraries for proteomics are becoming obsolete.

2019-03-13 | PXD010382 | Pride

FAIMS single cellUltrasensitive single-cell proteomics workflow identifies >1000 protein groups per mammalian cell

Project description:We report on the combination of nanodroplet sample preparation, ultra-low-flow nanoLC, high-field asymmetric ion mobility spectrometry (FAIMS), and the latest-generation Orbitrap Eclipse Tribrid mass spectrometer for greatly improved single-cell proteome coverage.

2020-11-24 | PXD019515 | Pride

FAIMS single cellUltrasensitive single-cell proteomics workflow identifies >1000 protein groups per mammalian cell

2020-12-21 | PXD022791 | Pride